KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
January 12, 2017 at 14:34 PM EST
On Monday, KemPharm Inc (NASDAQ: KMPH) reported encouraging results from its exploratory Phase 1 study assessing the pharmacokinetics, ...